Cryptocurrencies
AbbVie makes $380 million ‘made in the U.S.’ move
The Chicago-based biopharmaceutical company AbbVie made a significant move on Feb. 23, as part of its broader commitment to invest heavily in U.S. research and development over the next 10 years. AbbVie said it will Read more…